Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the “Company” or “Pure Global” or “PURE“), through its subsidiary PureSinse Inc., (“PureSinse“), is pleased to announce that Dr. Sanjeev Goel , a leading physician in medical cannabis has joined the PureSinse team as Chief Medical Officer.

Dr. Goel has a wealth of experience in medical cannabis and a pioneer in medical cannabis since 2015. He provides cutting-edge treatments to patients across the country and has led the formation of two resource centres for medical cannabis that have 3,000 patients registered with licensed producers in Canada . He was also founder and CEO for an integrative medical practice using cutting-edge medical treatments for patients across Canada .

Dr. Goel has been a transformative force in health care, founding a not-for-profit organization dedicated to empowering health care providers to improve patient care by becoming change agents. He also founded a healthcare software company to improve the quality of care physicians can offer their patients that led to the development of the largest primary care patient portal in Canada .

PureSinse looks forward to Dr. Goel serving as an integral member of the leadership team. As Chief Medical Officer, he will provide direction on projects supporting medical cannabis patients, notably the patient care experience and physician education.

“I am so excited to be a part of the Pure Global team. The company is truly focused on innovation in medical cannabis with the aim of helping patients across the globe, and that’s close to my heart.” said Dr. Goel upon joining.

Dr. Goel will act as the lead relationship partner with doctors and medical professionals, using his expertise in healthcare and IT to provide guidance on medical cannabis and systems to enable efficient, accurate patient care.

“I am thrilled to add Dr. Goel to our core team to help deliver patient-focused solutions enabling better education and ultimately improved patient outcomes”, said Malay Panchal, R.Ph., B.Sc.Phm., President & CEO of Pure Global. “Pure has a patient-centric focus and a clear vision for patient care. Dr. Goel’s extensive experience as a practicing physician will allow him to offer advice regarding clinical research projects, strategies to address the needs of wellness customers, and ways to integrate existing and new wellness products. He also brings a wealth of other skills to the organization.”

About Pure Global Cannabis

Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an innovations-based cannabis company led by experienced pharma, biotechnology, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and the Cannabis Act. The company’s Brampton campus will house facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. PURE will produce branded and white-labelled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.